- Is Macular Degeneration Foundation a tax-exempt 501(c)(3)?
- Yes. Macular Degeneration Foundation is recognised by the IRS as a 501(c)(3) organisation (EIN 65-0403437). The IRS recognised Macular Degeneration Foundation as tax-exempt in September 2022.
- What is Macular Degeneration Foundation's EIN?
- Macular Degeneration Foundation's Employer Identification Number (EIN) is 65-0403437. The EIN was assigned by the IRS in September 2022. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Macular Degeneration Foundation do?
- Bring awareness to and educate about Macular Degeneration. Provide information regarding new treatments and resources available. Provide general information about the disease fund grants to further research into the restoration of vision due to Macular Degeneration
- Where is Macular Degeneration Foundation located?
- Macular Degeneration Foundation is located at PO Box 531313, Henderson, NV, 89053.
- When was Macular Degeneration Foundation founded or recognised by the IRS?
- Macular Degeneration Foundation was recognised by the IRS as a tax-exempt organisation in September 2022. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Macular Degeneration Foundation's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Macular Degeneration Foundation reported $654K in total revenue and $682K in total expenses.
- Has Macular Degeneration Foundation been auto-revoked by the IRS?
- No. Macular Degeneration Foundation (EIN 65-0403437) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Macular Degeneration Foundation listed in IRS Publication 78?
- Yes. Macular Degeneration Foundation is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.